This series of articles addresses the challenges in managing hypoparathyroidism, offering healthcare professionals clear and actionable insights.
We’re delighted to highlight a new series of articles written by experts on hypoparathyroidism. This initiative brings together leading voices to share evidence-based perspectives, practical guidance and emerging research aimed at improving patient outcomes and advancing best practice regarding this rare and challenging endocrine condition.
Hypoparathyroidism is often under-recognised, yet its impact on quality of life can be profound. Beyond the biochemical markers, patients can face fluctuating symptoms, long-term complications and gaps in care pathways that require a nuanced, multidisciplinary approach.
YOU CAN FIND IT ONLINE NOW
Whether you’re looking to deepen your expertise or stay informed about current developments, this series is a valuable resource for clinicians, researchers and allied health professionals. By engaging with these articles, you will gain practical tools and fresh perspectives to support your work and enhance patient care.
Access the full series and join the conversation shaping the future of endocrine care.
FEATURED ARTICLES
Dr Zaki Hassan-Smith (Birmingham) explores common myths and misconceptions, highlighting why a holistic view of patient well-being matters as much as lab results.
Dr Afroze Abbas (Leeds) focuses on the often- overlooked long-term complications of the disease and examines strategies for monitoring and mitigating them.
Dr Victoria Stokes (Cambridge) sheds light on the challenges faced by women living with hypoparathyroidism, and advocates for more dynamic, patient-centred approaches.
Professor Peter Selby (Manchester) highlights gaps in the patient pathway for people with hypoparathyroidism, emphasising the need for regular monitoring, multidisciplinary collaboration, and patient empowerment to prevent long-term complications.
Helen Loo (Oxford) explores why biochemical stability alone does not fully reflect the lived experience of people with hypoparathyroidism, and discusses how formal quality‑of‑life tools can support more meaningful, consistent assessment.
Access all the articles
Acknowledgement: These articles have been supported and funded by Ascendis Pharma UK Ltd. Seeds of Change is a disease awareness initiative developed and funded by Ascendis Pharma UK Ltd and supported by Parathyroid UK and Society for Endocrinology.
